medmix publishes a midyear report as well as an annual report.
medmix, global leader in high-precision delivery devices, won the prestigious Good Design™ Award 2022 in the Medical category for PiccoJect™, the autoinjector from medmix Drug Delivery (Haselmeier™). PiccoJect™ is a disposable two-step autoinjector designed for subcutaneous injection.
medmix works with a UK distributor to defend trademark rights and remove counterfeit products imitating its COXTM handheld sealant and adhesive dispensers from sale. Having successfully identified an illegal supply route, medmix now supports the distributor by providing an OEM supply of genuine, high-quality dispensers.
Ad hoc announcement pursuant to Art. 53 LR
Stuttgart – medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and Hardware ecosystem.
medmix Switzerland Ltd is the global market leader in the design and production of manual, pneumatic and battery handheld sealant and adhesive applicators. In recent years nearly identical copies of such dispensers have been discovered on the market. These slavish imitations from other producers are not made under the strict quality control measures of medmix and therefore are not protected by its guarantee.
In line with its focus on establishing additional, cost-competitive manufacturing capacities, medmix has signed a business acquisition agreement for the entire plastics business of Universal de Suministros, S.L., Spain ("Universal").
Ad hoc announcement pursuant to Art. 53 LR
MIDYEAR 2022 HIGHLIGHTS
As a part of medmix, a global leader in high-precision delivery devices, GEKA (medmix Beauty) is releasing its first Sustainability report, outlining the commitment to and progress towards the company’s sustainability goals.
Ad hoc announcement pursuant to Art. 53 LR
Ad hoc announcement pursuant to Art. 53 LR
medmix is relocating production to other countries following an initial negative decision on sanctions unilaterally introduced by Poland. It is medmix’ firm belief that the sanctions against its entity in Poland are erroneous. The company continues its appeal process, with the full support of the Swiss government administration. medmix is not affected by any other sanctions and is free to develop its business globally.
medmix Drug Delivery introduces PiccoJect™, a disposable two-step autoinjector designed for subcutaneous injection. The device is being developed in two variants (PiccoJect™ 100 and PiccoJect™ 225) for a standard 1 ml long or 2.25 ml pre-filled glass or plastic syringes. With a focus on patient centric design and a commitment to sustainability, PiccoJect™ is composed of only eight parts and features an ergonomic shape and a large wrap-around drug window.
Ad hoc announcement pursuant to Art. 53 LR
medmix suspends the operations of its manufacturing site in Wroclaw, Poland as a result of sanctions levied by the Polish government. The sanctions apply to medmix’ minority shareholder, Viktor Vekselberg, but have been extended to medmix Poland, even though Mr. Vekselberg has no control or ownership of any medmix entities and is deprived of all his economic rights in medmix.